QC
WGS icon

Quadrature Capital’s GeneDx Holdings WGS Stock Holding History

Quadrature Capital’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
+20,422
New +$1.16M 0.01% 623
2025
Q2 		– Sell
-7,032
Closed -$624K – 1558
2025
Q1 		$624K Sell
7,032
-27,054
-79% -$2.35M 0.01% 523
2024
Q4 		$2.61M Buy
+34,086
New +$2.38M 0.05% 275

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Quadrature Capital's WGS Position: Q2 2026 in Review

Quadrature Capital opened a new position in GeneDx Holdings (WGS) in Q2 2026: 20,422 shares worth $1.4M. The stake represents 0.01% of the portfolio and ranks #623 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in WGS as recently as Q1 2025.

Quadrature Capital first reported a position in WGS in Q4 2024 and has held it in 3 quarters since. The position peaked at $2.61M in Q4 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Quadrature Capital held 20,422 shares of GeneDx Holdings worth $1.4M as of Q2 2026.
  • GeneDx Holdings was a new Quadrature Capital position in Q2 2026.
  • GeneDx Holdings made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #623 holding.
  • Quadrature Capital first reported a position in GeneDx Holdings in Q4 2024 and has held it in 3 quarters since.
  • Quadrature Capital's GeneDx Holdings position peaked at $2.61M in Q4 2024.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.